Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory effects of etomidate.

M Morgan, J Lumley, J G Whitwam

    British Journal of Anaesthesia
    |March 1, 1977
    PubMed
    Summary

    Etomidate (0.3 mg/kg) caused less respiratory depression than other intravenous agents. Opiate premedication reduced apnea incidence compared to non-narcotic options, though involuntary muscle movements persisted.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ultrasound treatment for breast engorgement: A randomised double blind trial.

    The Australian journal of physiotherapy·2014
    Same author

    Editorial-The next 50 years.

    Annals of the Royal College of Surgeons of England·2009
    Same author

    Brief antenatal cognitive behaviour therapy group intervention for the prevention of postnatal depression and anxiety: a randomised controlled trial.

    Journal of affective disorders·2007
    Same author

    Precancerous changes in the cervix and risk of subsequent preterm birth.

    BJOG : an international journal of obstetrics and gynaecology·2006
    Same author

    Interventions for promoting smoking cessation during pregnancy.

    The Cochrane database of systematic reviews·2004
    Same author

    How useful is the concept of somatization in cross-cultural studies of maternal depression? A contribution from the Mothers in a New Country (MINC) study.

    Journal of psychosomatic obstetrics and gynaecology·2003

    Area of Science:

    • Anesthesiology
    • Pharmacology

    Background:

    • Etomidate is an intravenous induction agent used in anesthesia.
    • Premedication strategies can influence anesthetic effects.
    • Respiratory depression is a key concern with induction agents.

    Purpose of the Study:

    • To compare the respiratory effects of etomidate (0.3 mg/kg) with different premedication regimens.
    • To evaluate the incidence of apnea and changes in respiratory parameters following etomidate administration.

    Main Methods:

    • A comparative study involving patients undergoing anesthesia.
    • Patients received etomidate 0.3 mg/kg after premedication with either diazepam and atropine (non-narcotic) or papaveretum and hyoscine (opiate).
    • Respiratory frequency and minute volume were monitored post-induction.

    Main Results:

    • Apnea occurred in 40% of patients with non-narcotic premedication versus 27% with opiate premedication.
    • Diazepam/atropine premedication led to a significant increase in respiratory frequency and minute volume.
    • Papaveretum/hyoscine premedication did not produce similar significant respiratory changes.
    • Involuntary muscle movements were observed during induction.

    Conclusions:

    • Etomidate appears to have a less pronounced effect on respiration compared to other intravenous induction agents.
    • Opiate premedication may mitigate the risk of apnea associated with etomidate.
    • Involuntary muscle movements remain a notable side effect requiring consideration.

    Related Experiment Videos